Clorox Stock Extends A 6-Day Losing Streak To An 11% Loss

A recent losing streak for Clorox stock coincides with signs of fundamental strain in the business.

Clorox (CLX) stock has fallen 11% over six consecutive trading days. This recent slide has erased about $1.5 billion from the company's market value, which now stands at about $12 billion.

The move has turned the stock's one-month return negative, to -2.2%, and deepened its trailing twelve-month return to -15.9%.

How The Streak Stacks Up Against The S&P 500

Here is how CLX stock stacks up against the S&P 500 over the streak and the periods around it:

The stock's decline reflects pressure in the underlying business.

The selling pressure appears to have fundamental roots. Revenue over the last twelve months declined 5.4%, which compares to an S&P 500 median revenue growth of 8.3%. The company's operating margin of 13.2% also sits below the S&P 500 median of 18.5%.

While the stock's price-to-earnings multiple of 19.7 is below the S&P 500 median of 23.2, the negative performance is specific to the stock; the S&P 500 returned -0.3% over the same 6 trading days. For context, 12 other S&P 500 stocks are currently on losing streaks of 6 days or more.

A streak is a prompt to re-evaluate, not a command to act.

A string of losses like this is information. It signals that the market's attention and momentum have turned negative, but it is not an instruction. The disciplined response is to use the moment to check the business against its price.

The fundamental data here provides a starting point for that assessment, weighing recent performance against longer-term business health and valuation.

A slide like this always poses the same follow-up: which marked-down stocks are actually worth buying? Our Buy the Dip screen runs that test every day, flagging beaten-down names whose fundamentals still hold up.

Prefer the theme to this single name? Our ETF Scorecard shows how the consumer staples funds stack up. It is still a concentrated bet on that one theme, though, which is exactly the gap the portfolio below closes.

A Slide Like This Is Why Diversification Exists

Watching one stock fall day after day is the clearest lesson the market teaches about single-name risk. Whether this particular decline is an opportunity or a warning, the deeper point is the same: no one name should be able to do this to your portfolio.

The Trefis High Quality (HQ) Portfolio is built on that principle: roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules. It has a track record of outpacing a benchmark that combines the three major indices - the S&P 500, S&P Mid-cap, and Russell 2000. Study the slide; spread the risk.